Literature DB >> 25680444

Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.

Yanling Huang1, Hang Yang, Junping Yu, Hongping Wei.   

Abstract

The novel phage lysin PlySs2, is reported to be highly active against various bacteria, including staphylococci, streptococci and Listeria. However, the molecular mechanisms underlying its broad lytic spectrum remain to be established. In the present study, the lytic activity of the catalytic domain (CD, PlySc) and binding specificity of the cell wall binding domain (CBD, PlySb) of PlySs2 were examined. Our results showed that PlySc alone maintains very limited lytic activity. Enhanced green fluorescent protein (EGFP)-fused PlySb displayed high binding affinity to the streptococcal strains tested, including S. suis, S. dysgalactiae, and S. agalactiae, but not staphylococci, supporting its utility as a good CBD donor for streptococcal-targeted lysin engineering. EGFP-fused intact PlySs2 similarly displayed high affinity for streptococci, but not staphylococci. Notably, four truncated PlySb fragments showed no binding capacity. These findings collectively indicate that integrity of the PlySc and PlySb domains is an essential determinant of the broad lytic activity of PlySs2.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680444      PMCID: PMC8200883          DOI: 10.1007/s12250-014-3535-6

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  22 in total

Review 1.  Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.

Authors:  Vincent A Fischetti
Journal:  Int J Med Microbiol       Date:  2010-05-10       Impact factor: 3.473

Review 2.  Enzybiotics: a look to the future, recalling the past.

Authors:  Patricia Veiga-Crespo; José Manuel Ageitos; Margarita Poza; Tomás G Villa
Journal:  J Pharm Sci       Date:  2007-08       Impact factor: 3.534

3.  PlyC: a multimeric bacteriophage lysin.

Authors:  Daniel Nelson; Raymond Schuch; Peter Chahales; Shiwei Zhu; Vincent A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

4.  Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa.

Authors:  Yves Briers; Maarten Walmagh; Barbara Grymonprez; Manfred Biebl; Jean-Paul Pirnay; Valerie Defraine; Jan Michiels; William Cenens; Abram Aertsen; Stefan Miller; Rob Lavigne
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

5.  X-ray crystal structure of the streptococcal specific phage lysin PlyC.

Authors:  Sheena McGowan; Ashley M Buckle; Michael S Mitchell; James T Hoopes; D Travis Gallagher; Ryan D Heselpoth; Yang Shen; Cyril F Reboul; Ruby H P Law; Vincent A Fischetti; James C Whisstock; Daniel C Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-17       Impact factor: 11.205

6.  Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme.

Authors:  Jinzhe Mao; Mathias Schmelcher; William J Harty; Juli Foster-Frey; David M Donovan
Journal:  FEMS Microbiol Lett       Date:  2013-03-15       Impact factor: 2.742

7.  Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187.

Authors:  M J Loessner; S Gaeng; S Scherer
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

8.  Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Pauline Yoong; Raymond Schuch; Daniel Nelson; Vincent A Fischetti
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

9.  Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.

Authors:  Pawan Kumar Singh; David M Donovan; Ashok Kumar
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

10.  Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.

Authors:  Daniel B Gilmer; Jonathan E Schmitz; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

View more
  13 in total

1.  Bacteriophages, revitalized after 100 years in the shadow of antibiotics.

Authors:  Hongping Wei
Journal:  Virol Sin       Date:  2015-02       Impact factor: 4.327

2.  Electrostatic-Mediated Affinity Tuning of Lysostaphin Accelerates Bacterial Lysis Kinetics and Enhances In Vivo Efficacy.

Authors:  Hongliang Zhao; Susan Eszterhas; Jacob Furlon; Hao Cheng; Karl E Griswold
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 3.  Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.

Authors:  Kegan S Sunderland; Mingying Yang; Chuanbin Mao
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-24       Impact factor: 15.336

4.  Expanding the Database of Signal-Anchor-Release Domain Endolysins Through Metagenomics.

Authors:  Marco Túlio Pardini Gontijo; Mateus Pereira Teles; Pedro Marcus Pereira Vidigal; Marcelo Brocchi
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-07       Impact factor: 4.609

5.  ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.

Authors:  Hang Yang; Yujing Gong; Huaidong Zhang; Irina Etobayeva; Paulina Miernikiewicz; Dehua Luo; Xiaohong Li; Xiaoxu Zhang; Krystyna Dąbrowska; Daniel C Nelson; Jin He; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

6.  A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus.

Authors:  Hang Yang; Huaidong Zhang; Jing Wang; Junping Yu; Hongping Wei
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

Review 7.  Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.

Authors:  Carlos São-José
Journal:  Antibiotics (Basel)       Date:  2018-03-22

8.  Contributions of Net Charge on the PlyC Endolysin CHAP Domain.

Authors:  Xiaoran Shang; Daniel C Nelson
Journal:  Antibiotics (Basel)       Date:  2019-05-28

9.  A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method.

Authors:  Hang Yang; Sara B Linden; Jing Wang; Junping Yu; Daniel C Nelson; Hongping Wei
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

10.  Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.

Authors:  Hang Yang; Mengyue Wang; Junping Yu; Hongping Wei
Journal:  Front Microbiol       Date:  2015-12-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.